Prediction of Effective Drug Combinations by Chemical Interaction, Protein Interaction and Target Enrichment of KEGG Pathways
暂无分享,去创建一个
Lei Chen | Yu-Dong Cai | Bi-Qing Li | Kai-Yan Feng | Jian Zhang | Yu-Dong Cai | Jian Zhang | Lei Chen | Kai-Yan Feng | Bi-Qing Li | Mingyue Zheng | Ming-Yue Zheng
[1] 中尾 光輝,et al. KEGG(Kyoto Encyclopedia of Genes and Genomes)〔和文〕 (特集 ゲノム医学の現在と未来--基礎と臨床) -- (データベース) , 2000 .
[2] Lei Chen,et al. Prediction of human genes' regulatory functions based on proteinprotein interaction network. , 2012, Protein and peptide letters.
[3] George W. Yip,et al. Therapeutic value of glycosaminoglycans in cancer , 2006, Molecular Cancer Therapeutics.
[4] Pierre Acklin,et al. Similarity Metrics for Ligands Reflecting the Similarity of the Target Proteins , 2003, J. Chem. Inf. Comput. Sci..
[5] X. Chen,et al. TTD: Therapeutic Target Database , 2002, Nucleic Acids Res..
[6] Chin Yee Liew,et al. QSAR classification of metabolic activation of chemicals into covalently reactive species , 2012, Molecular Diversity.
[7] H. Holmsen. Significance of testing platelet functions in vitro , 1994, European journal of clinical investigation.
[8] Kuo-Chen Chou,et al. Deciphering the effects of gene deletion on yeast longevity using network and machine learning approaches. , 2012, Biochimie.
[9] Vinhthuy T. Phan,et al. Chemical genomics of cancer chemopreventive dithiolethiones , 2009, Carcinogenesis.
[10] Kuo-Chen Chou,et al. Predicting the network of substrate-enzyme-product triads by combining compound similarity and functional domain composition , 2010, BMC Bioinformatics.
[11] Susumu Goto,et al. KEGG for representation and analysis of molecular networks involving diseases and drugs , 2009, Nucleic Acids Res..
[12] Torsten Seemann,et al. Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKR , 2011, PLoS pathogens.
[13] Yu-Dong Cai,et al. Prediction of Deleterious Non-Synonymous SNPs Based on Protein Interaction Network and Hybrid Properties , 2010, PloS one.
[14] Xing-Ming Zhao,et al. The drug cocktail network , 2012, BMC Systems Biology.
[15] C. Ding,et al. Gene selection algorithm by combining reliefF and mRMR , 2007, 2007 IEEE 7th International Symposium on BioInformatics and BioEngineering.
[16] R. Sun,et al. Closed-loop control of cellular functions using combinatory drugs guided by a stochastic search algorithm , 2008, Proceedings of the National Academy of Sciences.
[17] Fuhui Long,et al. Feature selection based on mutual information criteria of max-dependency, max-relevance, and min-redundancy , 2003, IEEE Transactions on Pattern Analysis and Machine Intelligence.
[18] H. Bischoff. Pharmacology of α-glucosidase inhibition , 1994 .
[19] Peer Bork,et al. Extraction of regulatory gene/protein networks from Medline , 2006, Bioinform..
[20] David Allard,et al. Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer , 2009, Science.
[21] K. Chou,et al. Predicting Anatomical Therapeutic Chemical (ATC) Classification of Drugs by Integrating Chemical-Chemical Interactions and Similarities , 2012, PloS one.
[22] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[23] Xing-Ming Zhao,et al. Prediction of Drug Combinations by Integrating Molecular and Pharmacological Data , 2011, PLoS Comput. Biol..
[24] H. Gutmann,et al. Primary porcine proximal tubular cells as a model for transepithelial drug transport in human kidney. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[25] H. Yee,et al. A Review of the Safety and Efficacy of Acarbose in Diabetes Mellitus , 1996, Pharmacotherapy.
[26] C. Steinbeck,et al. Recent developments of the chemistry development kit (CDK) - an open-source java library for chemo- and bioinformatics. , 2006, Current pharmaceutical design.
[27] Christian von Mering,et al. STRING 8—a global view on proteins and their functional interactions in 630 organisms , 2008, Nucleic Acids Res..
[28] J. Lehár,et al. Systematic discovery of multicomponent therapeutics , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[29] W. Eanes,et al. Direct Evidence That Genetic Variation in Glycerol-3-Phosphate and Malate Dehydrogenase Genes (Gpdh and Mdh1) Affects Adult Ethanol Tolerance in Drosophila melanogaster , 2009, Genetics.
[30] M. Venkatesh,et al. Generic antibiotic industries: Challenges and implied strategies with regulatory perspectives , 2011, Journal of pharmacy & bioallied sciences.
[31] Tongliang Zhang,et al. Using pseudo amino acid composition and binary-tree support vector machines to predict protein structural classes , 2007, Amino Acids.
[32] M. Ouellette,et al. Drug Uptake and Modulation of Drug Resistance in Leishmania by an Aquaglyceroporin* , 2004, Journal of Biological Chemistry.
[33] Michael J. Keiser,et al. Predicting new molecular targets for known drugs , 2009, Nature.
[34] Yoshihiro Yamanishi,et al. Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework , 2010, Bioinform..
[35] Ron Kohavi,et al. A Study of Cross-Validation and Bootstrap for Accuracy Estimation and Model Selection , 1995, IJCAI.
[36] Duane D. Miller,et al. Micellar Delivery of Bicalutamide and Embelin for Treating Prostate Cancer , 2009, Pharmaceutical Research.
[37] P. Bork,et al. Literature mining for the biologist: from information retrieval to biological discovery , 2006, Nature Reviews Genetics.
[38] Xing-Ming Zhao,et al. A systems biology approach to identify effective cocktail drugs , 2010, BMC Systems Biology.
[39] R. Blaheta,et al. Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axis , 2011, BMC Cancer.
[40] J. Verweij,et al. Multiple targeted tyrosine kinase inhibition in the clinic: all for one or one for all? , 2006, European journal of cancer.
[41] F. Leroux,et al. Inhibitors of steroidal cytochrome p450 enzymes as targets for drug development. , 2007, Recent patents on anti-cancer drug discovery.
[42] Xiaohua Ma,et al. Mechanisms of drug combinations: interaction and network perspectives , 2009, Nature Reviews Drug Discovery.
[43] Claus Lundegaard,et al. NetTurnP – Neural Network Prediction of Beta-turns by Use of Evolutionary Information and Predicted Protein Sequence Features , 2010, PloS one.
[44] J. T. Sanderson,et al. The steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicals. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[45] A. Balmain,et al. How many mutations are required for tumorigenesis? implications from human cancer data , 1993 .
[46] P. Bork,et al. Drug Target Identification Using Side-Effect Similarity , 2008, Science.
[47] Kuo-Chen Chou,et al. Predicting Biological Functions of Compounds Based on Chemical-Chemical Interactions , 2011, PloS one.
[48] Leming Shi,et al. Identifying Unexpected Therapeutic Targets via Chemical-Protein Interactome , 2010, PloS one.
[49] N. Zisapel,et al. A novel decoy that interrupts G93A-superoxide dismutase gain of interaction with malate dehydrogenase improves survival in an amyotrophic lateral sclerosis cell model. , 2009, Journal of medicinal chemistry.
[50] K. Chou,et al. Predicting Drug-Target Interaction Networks Based on Functional Groups and Biological Features , 2010, PloS one.
[51] Y. Martin,et al. Do structurally similar molecules have similar biological activity? , 2002, Journal of medicinal chemistry.
[52] Kuo-Chen Chou,et al. Predicting Functions of Proteins in Mouse Based on Weighted Protein-Protein Interaction Network and Protein Hybrid Properties , 2011, PloS one.
[53] B. Aggarwal,et al. Models for prevention and treatment of cancer: problems vs promises. , 2009, Biochemical pharmacology.
[54] B. Matthews. Comparison of the predicted and observed secondary structure of T4 phage lysozyme. , 1975, Biochimica et biophysica acta.
[55] Zhirong Sun,et al. CTKPred: an SVM-based method for the prediction and classification of the cytokine superfamily. , 2005, Protein engineering, design & selection : PEDS.
[56] Ian Witten,et al. Data Mining , 2000 .
[57] J. Ioannidis,et al. Most meta-analyses of drug interventions have narrow scopes and many focus on specific agents. , 2013, Journal of clinical epidemiology.
[58] John C Ashton,et al. Drug combination studies and their synergy quantification using the Chou-Talalay method--letter. , 2015, Cancer research.
[59] Tom Fawcett,et al. An introduction to ROC analysis , 2006, Pattern Recognit. Lett..
[60] Lei Chen,et al. Prediction of Metabolic Pathway Using Graph Property, Chemical Functional Group and Chemical Structural Set , 2013 .
[61] Gajendra P. S. Raghava,et al. GPCRpred: an SVM-based method for prediction of families and subfamilies of G-protein coupled receptors , 2004, Nucleic Acids Res..
[62] อนิรุธ สืบสิงห์,et al. Data Mining Practical Machine Learning Tools and Techniques , 2014 .
[63] Claudiu T. Supuran,et al. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators , 2008, Nature Reviews Drug Discovery.
[64] Pierre Baldi,et al. Assessing the accuracy of prediction algorithms for classification: an overview , 2000, Bioinform..
[65] Xue-jun Li,et al. [Differential protein analysis in rat renal proximal tubule epithelial cells in response to acetazolamide and its relation with the inhibition of AQP1]. , 2003, Yao xue xue bao = Acta pharmaceutica Sinica.
[66] Christian von Mering,et al. STITCH: interaction networks of chemicals and proteins , 2007, Nucleic Acids Res..
[67] John B. O. Mitchell. The Relationship between the Sequence Identities of Alpha Helical Proteins in the PDB and the Molecular Similarities of Their Ligands , 2001, J. Chem. Inf. Comput. Sci..
[68] D Hare,et al. The Orange Book: the Food and Drug Administration's advice on therapeutic equivalence. , 1990, American pharmacy.
[69] A. Esmaeili,et al. Prediction of GABAA receptor proteins using the concept of Chou's pseudo-amino acid composition and support vector machine. , 2011, Journal of theoretical biology.
[70] David S. Wishart,et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..
[71] Blaise Lippa,et al. The Hedgehog signaling pathway as a target for anticancer drug discovery. , 2005, Current topics in medicinal chemistry.
[72] T. Chou. Drug combination studies and their synergy quantification using the Chou-Talalay method. , 2010, Cancer research.
[73] J. Carazo,et al. GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists , 2007, Genome Biology.
[74] J. Lehár,et al. Multi-target therapeutics: when the whole is greater than the sum of the parts. , 2007, Drug discovery today.
[75] John M. Barnard,et al. Chemical Similarity Searching , 1998, J. Chem. Inf. Comput. Sci..
[76] Xin Chen,et al. DCDB: Drug combination database , 2010, Bioinform..
[77] R. Madhubala,et al. Role of aquaglyceroporin (AQP1) gene and drug uptake in antimony-resistant clinical isolates of Leishmania donovani. , 2008, The American journal of tropical medicine and hygiene.
[78] T. West,et al. Staphylococcus aureus disease and drug resistance in resource-limited countries in south and east Asia. , 2009, The Lancet. Infectious diseases.
[79] Susan E. Abbatiello,et al. Erratum: Synergistic drug combinations tend to improve therapeutically relevant selectivity , 2009, Nature Biotechnology.
[80] P. Bork,et al. Network Neighbors of Drug Targets Contribute to Drug Side-Effect Similarity , 2011, PloS one.
[81] Linda J. Broadbelt,et al. In silico feasibility of novel biodegradation pathways for 1,2,4-trichlorobenzene , 2010, BMC Systems Biology.